33 pending office actions • 24 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18837906 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | Kemira Oyj | VERA, ELISA H | 1748 | Non-Final OA | Aug 13, 2024 |
| 18837911 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | Kemira Oyj | VERA, ELISA H | 1748 | Non-Final OA | Aug 13, 2024 |
| 18695839 | RUXOLITINIB COMPOSITION AND PREPARATION METHOD THEREFOR | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | ALAM, AYAAN A | 1611 | Non-Final OA | Mar 27, 2024 |
| 18695384 | POLYCYCLIC FUSED RING DERIVATIVES AND USE THEREOF | Jacobio Pharmaceuticals Co., Ltd. | JARRELL, NOBLE E | 1699 | Non-Final OA | Mar 26, 2024 |
| 18613714 | GLP-1 Receptor Agonist and Composition and Use Thereof | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | HABTE, KAHSAY | 1624 | Final Rejection | Mar 22, 2024 |
| 18691908 | SOLID FORM OF RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, PREPARATION METHOD AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO., LTD. | MOU, LIYUAN | 1628 | Non-Final OA | Mar 14, 2024 |
| 18581446 | NUCLEIC ACIDS ENCODING HUMANIZED ANTI-PACAP ANTIBODIES | H. Lundbeck A/S | HOWARD, ZACHARY C | 1674 | Final Rejection | Feb 20, 2024 |
| 18684203 | N-CYCLOPROPYLPYRIDO [4, 3-D] PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF | Jacobio Pharmaceuticals Co., Ltd. | MARTIN, KEVIN STEPHEN | 1624 | Non-Final OA | Feb 16, 2024 |
| 18684205 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | Jacobio Pharmaceuticals Co., Ltd. | MOU, LIYUAN | 1628 | Non-Final OA | Feb 16, 2024 |
| 18392143 | COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO | The University of British Columbia | SHOMER, ISAAC | 1612 | Non-Final OA | Dec 21, 2023 |
| 18561909 | Compound containing phosphate group, pharmaceutical composition containing same, preparation method therefor and use thereof | Shanghai Raising Pharmaceutical Co., Ltd. | O DELL, DAVID K | 1621 | Non-Final OA | Nov 17, 2023 |
| 18283468 | NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE | Aptacure Therapeutics Limited | SHIN, DANA H | 1635 | Non-Final OA | Oct 25, 2023 |
| 18284897 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | Jacobio Pharmaceuticals Co., Ltd. | MCMILLIAN, KARA RENITA | 1623 | Non-Final OA | Sep 29, 2023 |
| 18283385 | MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING | Innate Pharma | JOHNSON, TIRONE DEREK | 1675 | Non-Final OA | Sep 21, 2023 |
| 18282711 | GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO | Incisive Genetics, Inc. | TATGE, LEXUS MARC | 1637 | Non-Final OA | Sep 18, 2023 |
| 18278639 | CO-EXPRESSED CXCR2 AND T CELLS OF STAR SPECIFIC TO GPC3, AND USE THEREOF | (Shanghai Icell Biotechnology Co., Ltd.) | LEE, YIE CHIA | 1642 | Non-Final OA | Sep 06, 2023 |
| 18278646 | VILLI STROMAL CELLS COMPOSITIONS AND USES THEREOF | Arugula Sciences LLC | TICHY, JENNIFER M.H. | 1653 | Non-Final OA | Aug 24, 2023 |
| 18271106 | NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF | Immunext, Inc. | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Jul 06, 2023 |
| 18346961 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | Alderbio Holdings LLC | BORGEEST, CHRISTINA M | 1675 | Final Rejection | Jul 05, 2023 |
| 18269783 | PHARMACEUTICAL COMPOSITION CONTAINING PYRROLOQUINOLINE QUINONE TRILITHIUM SALT NONAHYDRATE COMPOUND, CAPSULE, AND PREPARATION METHOD THEREFOR | Shanghai Raising Pharmaceutical Co., Ltd. | MARTIN, KEVIN STEPHEN | 1624 | Non-Final OA | Jun 27, 2023 |
| 18037809 | KRAS G12D Inhibitors | Jacobio Pharmaceuticals Co., Ltd. | HASTINGS, ALISON AZAR | 1627 | Non-Final OA | May 19, 2023 |
| 18029400 | EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR | BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE | AEDER, SEAN E | 1642 | Non-Final OA | May 04, 2023 |
| 18030801 | METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS | The Trustees of Dartmouth College | MYERS, CARLA J | 1682 | Non-Final OA | Apr 07, 2023 |
| 18295454 | CHIMERIC ANTIGEN RECEPTOR, REGULATORY CELLS AND METHODS OF USE | The Trustees of Dartmouth College | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Apr 04, 2023 |
| 18023405 | PREPARATION METHOD FOR NOVEL RHO-RELATED PROTEIN KINASE INHIBITOR AND INTERMEDIATE IN PREPARATION METHOD | BEIJING TIDE PHARMACEUTICAL CO., LTD. | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Feb 27, 2023 |
| 18015096 | PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shanghai Raising Pharmaceutical Co., Ltd. | JAVANMARD, SAHAR | 1622 | Final Rejection | Jan 09, 2023 |
| 18064514 | CHIMERIC ANTIGEN RECEPTORS TARGETING TIM-1 | Celldex Therapeurics, Inc. | SKELDING, ZACHARY S | 1644 | Non-Final OA | Dec 12, 2022 |
| 18008278 | Improved T cell receptor-costimulatory molecule chimera | Tsinghua University | CHATTIN, AMY MARIE | 1643 | Non-Final OA | Dec 05, 2022 |
| 17920445 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | Immunext, Inc. | CANELLA, KAREN A | 1643 | Non-Final OA | Oct 21, 2022 |
| 17910401 | COMPOSITIONS AND METHODS FOR INCREASED WET AND DRY STRENGTH | Kemira Oyj | RUSSELL, STEPHEN MATTHEW | 1748 | Non-Final OA | Sep 09, 2022 |
| 17782252 | ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION | The Trustees of Dartmouth College | MATALKAH, FATIMAH KHALAF | 1638 | Non-Final OA | Jun 03, 2022 |
| 17769779 | POLYAMIDE SEA-ISLAND FIBER, PREPARATION METHOD THEREFOR, AND USE THEREOF | Cathay (Wusu) Biomaterial Co., Ltd. | JOHNSON, JENNA LEIGH | 1789 | Non-Final OA | Apr 18, 2022 |
| 17642485 | DCR3 VARIANT | Kyowa Kirin Co., Ltd. | REYNOLDS, FRED H | 1658 | Final Rejection | Mar 11, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial